Medical technology - Articles - Page 7370

Biotech-Big Pharma Collaborations: Modified And Terminated Agreements, June 17 - Aug. 26, 2004#

Aug. 30, 2004

Biotech-Big Pharma Collaborations: New Agreements, June 17 - Aug. 26, 2004#

Aug. 30, 2004

U.S. Patent Disclosures

Aug. 30, 2004

No Vote At FDA Advisory Panel For Eyetech, Pfizer's Macugen

Aug. 30, 2004

By Kim Coghill

ROCKVILLE, Md. - An FDA advisory panel Friday leaned toward favoring Macugen, a proposed treatment for age-related macular degeneration expected to have an impact on the aging Baby Boomer population. (BioWorld Today)

Other News To Note

Aug. 27, 2004

Gilead's Combo Beats Glaxo Pill At 24-Week Study Mark

Aug. 27, 2004

Eyetech, Pfizer Go Before FDA Panel With Macugen

Aug. 27, 2004

By Kim Coghill

Eyetech Pharmaceuticals Inc. and partner Pfizer Inc. today are scheduled to present data supporting use of the potential blockbuster Macugen as a treatment for neovascular or wet age-related macular degeneration. (BioWorld Today)